Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.3M | 258 | 55.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $392,085 | 68 | 16.5% |
| Travel and Lodging | $326,043 | 325 | 13.7% |
| Acquisitions | $123,728 | 2 | 5.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $95,770 | 5 | 4.0% |
| Unspecified | $44,548 | 6 | 1.9% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $28,667 | 3 | 1.2% |
| Food and Beverage | $19,815 | 233 | 0.8% |
| Honoraria | $10,888 | 6 | 0.5% |
| Grant | $3,500 | 1 | 0.1% |
| Education | $460.22 | 2 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $753,558 | 285 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $422,946 | 146 | $0 (2024) |
| Biocompatibles, Inc. | $340,741 | 44 | $0 (2019) |
| BTG International Canada Inc. | $231,741 | 14 | $0 (2018) |
| Eisai Inc. | $147,152 | 102 | $0 (2024) |
| Siemens Medical Solutions USA, Inc. | $81,767 | 101 | $0 (2024) |
| Cook Incorporated | $70,584 | 16 | $0 (2024) |
| BTG International, Inc. | $49,172 | 8 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $38,443 | 25 | $0 (2024) |
| Sirtex Medical Inc | $34,750 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $365,923 | 200 | Boston Scientific Corporation ($196,758) |
| 2023 | $389,938 | 182 | Boston Scientific Corporation ($146,509) |
| 2022 | $344,188 | 129 | BOSTON SCIENTIFIC CORPORATION ($230,172) |
| 2021 | $217,346 | 76 | Bard Peripheral Vascular, Inc. ($96,937) |
| 2020 | $208,951 | 83 | Boston Scientific Corporation ($76,668) |
| 2019 | $232,957 | 73 | Biocompatibles, Inc. ($151,474) |
| 2018 | $389,942 | 110 | Biocompatibles, Inc. ($168,513) |
| 2017 | $223,466 | 56 | BTG International Canada Inc. ($152,457) |
All Payment Transactions
909 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 12/17/2024 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $910.00 | General |
| 12/14/2024 | Boston Scientific Corporation | TheraSphere Administration Set (Device) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: TheraSphere Administration Set_PI | ||||||
| 12/11/2024 | Eisai Inc. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $4,400.00 | General |
| Category: Oncology | ||||||
| 12/03/2024 | TriSalus Life Sciences, Inc. | TRINAV INFUSION SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $20,000.00 | General |
| Category: ONCOLOGY | ||||||
| 11/24/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $755.00 | General |
| 11/24/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $755.00 | General |
| 11/21/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,800.00 | General |
| Category: TheraSphere_PI | ||||||
| 11/21/2024 | Boston Scientific Corporation | — | Grant | In-kind items and services | $3,500.00 | General |
| Category: General - Therapies_PI | ||||||
| 11/21/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: TheraSphere_PI | ||||||
| 11/21/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Travel and Lodging | Cash or cash equivalent | $398.29 | General |
| Category: TheraSphere_PI | ||||||
| 11/21/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Travel and Lodging | Cash or cash equivalent | $163.57 | General |
| Category: TheraSphere_PI | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $3,020.00 | General |
| 11/15/2024 | TriSalus Life Sciences, Inc. | TRINAV INFUSION SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $4,225.00 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,565.00 | General |
| 11/15/2024 | Genentech, Inc. | — | Travel and Lodging | In-kind items and services | $463.35 | General |
| 11/15/2024 | Genentech, Inc. | — | Travel and Lodging | In-kind items and services | $393.28 | General |
| 11/15/2024 | Genentech, Inc. | — | Travel and Lodging | Cash or cash equivalent | $352.79 | General |
| 11/15/2024 | Genentech, Inc. | — | Food and Beverage | In-kind items and services | $218.85 | General |
| 11/15/2024 | Boston Scientific Corporation | EMBOLD Fibered (Device) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Embold_PI | ||||||
| 11/14/2024 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| Category: Interventional Oncology | ||||||
| 11/12/2024 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $812.50 | General |
| 11/09/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Food and Beverage | In-kind items and services | $396.86 | General |
| Category: TheraSphere_PI | ||||||
| 11/08/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Food and Beverage | In-kind items and services | $601.80 | General |
| Category: TheraSphere_PI | ||||||
| 11/07/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Food and Beverage | In-kind items and services | $191.95 | General |
| Category: TheraSphere_PI | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PROTEUS | BARD PERIPHERAL VASCULAR, INC. | $10,528 | 1 |
| PROTEUS | Bard Peripheral Vascular, Inc. | $9,860 | 1 |
| PROTEUS PROJECT | Bard Peripheral Vascular, Inc. | $2,500 | 1 |
| A PHASE III, OPEN-LABEL, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF ATEZOLIZUMAB IN COMBINATION WITH BEVACIZUMAB VERSUS SORAFENIB IN PATIENTS WITH UNTREATED ADVANCED HEPATOCELLULAR CARCINOMA HCC | F. Hoffmann-La Roche AG | $2,110 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 272 | 292 | $140,254 | $16,975 |
| 2022 | 6 | 228 | 234 | $136,328 | $16,450 |
| 2021 | 7 | 342 | 344 | $216,224 | $26,445 |
| 2020 | 4 | 106 | 111 | $62,948 | $8,314 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36561 | Insertion of central venous tube with port (5 years or older) | Facility | 2023 | 21 | 21 | $52,542 | $5,871 | 11.2% |
| 36558 | Insertion of tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 15 | 16 | $29,328 | $3,342 | 11.4% |
| 49440 | Insertion of stomach tube using fluoroscopic guidance with contrast | Facility | 2023 | 11 | 11 | $14,168 | $1,806 | 12.7% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 22 | 23 | $14,973 | $1,699 | 11.3% |
| 50435 | Replacement of kidney drainage tube using imaging guidance with review by radiologist | Facility | 2023 | 11 | 15 | $10,355 | $1,411 | 13.6% |
| 77001 | Fluoroscopic guidance for insertion or removal of central vein access device | Facility | 2023 | 57 | 61 | $5,917 | $944.71 | 16.0% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 68 | 73 | $6,132 | $911.78 | 14.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 54 | 59 | $3,953 | $660.19 | 16.7% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 13 | 13 | $2,886 | $330.32 | 11.4% |
| 36561 | Insertion of central venous tube with port (5 years or older) | Facility | 2022 | 22 | 23 | $57,546 | $6,925 | 12.0% |
| 36558 | Insertion of tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 21 | 21 | $38,493 | $4,712 | 12.2% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 25 | 25 | $16,275 | $1,648 | 10.1% |
| 77001 | Fluoroscopic guidance for insertion or removal of central vein access device | Facility | 2022 | 74 | 75 | $7,275 | $1,176 | 16.2% |
| 50435 | Replacement of kidney drainage tube using imaging guidance with review by radiologist | Facility | 2022 | 12 | 14 | $10,355 | $1,124 | 10.9% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2022 | 74 | 76 | $6,384 | $864.97 | 13.5% |
| 36561 | Insertion of central venous catheter and implanted device for infusion beneath the skin, patient 5 years or older | Facility | 2021 | 43 | 43 | $107,586 | $12,973 | 12.1% |
| 36558 | Insertion of central venous catheter for infusion, patient 5 years or older, tunneled | Facility | 2021 | 28 | 28 | $51,324 | $6,365 | 12.4% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 27 | 27 | $17,577 | $2,023 | 11.5% |
| 36581 | Replacement of central venous catheter, tunneled without port or pump | Facility | 2021 | 12 | 12 | $19,140 | $1,844 | 9.6% |
| 77001 | Fluoroscopic guidance for insertion, replacement or removal of central venous access device | Facility | 2021 | 107 | 109 | $10,573 | $1,785 | 16.9% |
| 76937 | Ultrasound guidance for accessing into blood vessel | Facility | 2021 | 97 | 97 | $8,148 | $1,153 | 14.1% |
| 99152 | Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | Facility | 2021 | 28 | 28 | $1,876 | $302.96 | 16.1% |
| 36561 | Insertion of central venous catheter and implanted device for infusion beneath the skin, patient 5 years or older | Facility | 2020 | 14 | 14 | $35,028 | $4,410 | 12.6% |
| 36558 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 11 | 11 | $20,163 | $2,655 | 13.2% |
| 77001 | Fluoroscopic guidance for insertion, replacement or removal of central venous access device | Facility | 2020 | 39 | 41 | $3,977 | $678.13 | 17.1% |
About Dr. Riad Salem, MD
Dr. Riad Salem, MD is a Vascular & Interventional Radiology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164447645.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Riad Salem, MD has received a total of $2.4M in payments from pharmaceutical and medical device companies, with $365,923 received in 2024. These payments were reported across 909 transactions from 34 companies. The most common payment nature is "Consulting Fee" ($1.3M).
As a Medicare-enrolled provider, Salem has provided services to 948 Medicare beneficiaries, totaling 981 services with total Medicare billing of $68,184. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Vascular & Interventional Radiology
- Location Chicago, IL
- Active Since 07/13/2006
- Last Updated 07/08/2007
- Taxonomy Code 2085R0204X
- Entity Type Individual
- NPI Number 1164447645
Products in Payments
- THERASPHERE - BIO (Device) $616,962
- TheraSphere Y90 Glass Microspheres 10 GBq (Device) $370,689
- Lenvima (Drug) $147,118
- General - Therapies (Device) $111,422
- GENERAL - THERAPIES (Device) $67,781
- TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) $46,354
- SIR-Spheres Microspheres (Device) $34,750
- GENERAL PAIN MANAGEMENT (Device) $32,608
- TRINAV INFUSION SYSTEM (Device) $25,484
- GENERAL THERAPIES (Device) $24,800
- IMFINZI (Biological) $18,679
- TECENTRIQ (Biological) $18,564
- THERASPHERE (Device) $17,525
- SMART PORT CT (Device) $15,600
- TheraSphere (Device) $13,650
- Tecentriq (Biological) $11,774
- Clinical Trial Product (Device) $10,325
- Cook Medical Embolization (Device) $9,169
- Embosphere Microspheres (Device) $8,925
- Wrapsody Stent Graft (Device) $8,497
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Vascular & Interventional Radiology Doctors in Chicago
Dr. Kush Desai, M.d, M.D
Vascular & Interventional Radiology — Payments: $1.0M
Robert Lewandowski, Md, MD
Vascular & Interventional Radiology — Payments: $882,934
Osmanuddin Ahmed, Md, MD
Vascular & Interventional Radiology — Payments: $660,213
Dr. Sreekumar Madassery, M.d, M.D
Vascular & Interventional Radiology — Payments: $515,261
Dr. Christopher Molvar, Md, MD
Vascular & Interventional Radiology — Payments: $506,500
Dr. Bulent Arslan, M.d, M.D
Vascular & Interventional Radiology — Payments: $330,674